IRIS
GREMESE, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.328
NA - Nord America 2.575
SA - Sud America 962
EU - Europa 569
AF - Africa 65
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.473
SG - Singapore 2.304
BR - Brasile 834
CN - Cina 488
VN - Vietnam 187
HK - Hong Kong 93
GB - Regno Unito 76
DE - Germania 74
IT - Italia 71
IN - India 61
RU - Federazione Russa 58
CA - Canada 51
AR - Argentina 45
FI - Finlandia 43
BD - Bangladesh 40
CZ - Repubblica Ceca 36
FR - Francia 36
IE - Irlanda 32
MX - Messico 31
SE - Svezia 27
IQ - Iraq 26
EC - Ecuador 25
JP - Giappone 22
PL - Polonia 21
ZA - Sudafrica 21
CO - Colombia 19
NL - Olanda 18
TR - Turchia 15
UA - Ucraina 14
ES - Italia 13
MA - Marocco 13
PK - Pakistan 13
ID - Indonesia 12
LT - Lituania 12
PY - Paraguay 11
VE - Venezuela 11
AT - Austria 10
BE - Belgio 10
NG - Nigeria 10
AZ - Azerbaigian 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
CL - Cile 7
KE - Kenya 7
IL - Israele 6
JO - Giordania 6
AU - Australia 5
EG - Egitto 5
IR - Iran 5
SA - Arabia Saudita 5
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CH - Svizzera 3
DZ - Algeria 3
GT - Guatemala 3
JM - Giamaica 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
KR - Corea 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RE - Reunion 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.506
Salva come PNG Salva come JPEG
Città #
Singapore 719
The Dalles 618
Dallas 387
Ashburn 282
Shanghai 279
Beijing 138
Chandler 117
Hong Kong 91
Ho Chi Minh City 83
São Paulo 75
Boardman 71
Los Angeles 60
New York 54
Santa Clara 49
Helsinki 42
Hanoi 38
Dublin 31
Rio de Janeiro 31
Brooklyn 29
Wilmington 28
Belo Horizonte 26
Brno 24
Chennai 24
London 22
Stockholm 22
Tokyo 22
Curitiba 21
Paris 19
Warsaw 19
Chicago 18
Munich 18
Toronto 18
Campinas 17
Montreal 17
Phoenix 16
Assago 14
Brasília 13
Lawrence 13
Princeton 13
Frankfurt am Main 12
Goiânia 12
Olomouc 12
Reston 12
Salvador 12
San Francisco 12
Ankara 11
Atlanta 11
Council Bluffs 11
Denver 11
Mexico City 11
Santo André 11
Brussels 10
Johannesburg 10
Moscow 10
Naples 10
San Mateo 10
Amsterdam 9
Baku 9
Boston 9
Dhaka 9
Milan 8
São Bernardo do Campo 8
Tashkent 8
Benin City 7
Guarulhos 7
Haiphong 7
Lahore 7
Orem 7
Piracicaba 7
Poplar 7
Quito 7
Sorocaba 7
Valparaíso de Goiás 7
Amman 6
Asunción 6
Baghdad 6
Betim 6
Biên Hòa 6
Bogotá 6
Caxias do Sul 6
Charlotte 6
Fortaleza 6
Juiz de Fora 6
Manchester 6
Ribeirão das Neves 6
Seattle 6
Ann Arbor 5
Bengaluru 5
Cape Town 5
Collegeville 5
Formosa 5
Guayaquil 5
Leawood 5
Maceió 5
Mumbai 5
Nairobi 5
New Delhi 5
Ottawa 5
Pelotas 5
Porto Alegre 5
Totale 4.044
Salva come PNG Salva come JPEG
Nome #
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 96
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 93
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 77
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 76
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 70
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 70
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 65
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 63
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. 62
Access of arthritis patients to an early arthritis clinic in three different settings: the very early ra represents the best clinical and therapeutic opportunity to reach das remission. Quality indicators (QI) of the italian ministry of health program 56
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study 56
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 53
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 48
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 47
An unusual lung involvement in scleroderma: lipoid pneumonia 46
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report 45
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 45
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 42
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature 42
A brief battery for the evaluation of cognitive deficits in italian SLE patients 42
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 42
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 41
A brief battery for the evaluation of cognitive deficits in italian SLE patients 41
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 40
Adult onset Still's disease and pregnancy 40
[Class IV-G and IV-S lupus nephritis, interstitial infiltrates and prognosis: state of the art and unmet medical needs] 40
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles (of the responders) 39
Biologics use in SLE in 23 centers – data from the international registry for biologics in SLE 38
IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy 38
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results 38
ACPA–IL-6 as the best biomarkers to differentiate early rheumatoid arthritis from undifferentiated arthritis: analysis of the diagnostic performance 38
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years 38
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 38
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study 37
Synovial B cells of rheumatoid arthritis express ZAP-70 which increases the survival and correlates with the inflammatory and autoimmune phenotype 37
Cancer in connective tissue disease 37
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 37
The Role of Microrna-34 and Microrna-22 in Dendritic Cells and Monocyte Activation in Rheumatoid Arthritis 35
Peripheral blood B cells subsets in patients with systemic lupus erythematosus: correlation with disease activity and organ involvement 34
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis 34
Definition of fibromyalgia severity: Findings from a cross-sectional survey of 2339 Italian patients 33
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 33
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 33
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 33
Off-label use of rituximab for SLE in Europe: a comparison to patients treated with conventional immunosuppressive medications 32
Association of the 22 genotype of enhancer HS1,2A of the Ig heavy 3′ regulatory region with non response to DMARDS and response to rituximab in rheumatoid arthritis patients 32
Circulating Human Collagen II-Reactive T Cell in Early Rheumatoid Arthritis Produce IL17. 31
Artrite Reumatoide 31
Spondiloartriti sieronegative 31
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 31
B-lymphocyte stimulator (BLYS) in rheumatoid arthritis: clinical, biological and prognostic relevance 31
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 30
Different levels of TCR-zeta chain and ZAP-70 characterize distinct subsets of T CD28null lymphocytes in arthritis patients 30
Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association 30
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis 30
Circulating memory B cells characterize active nephritis instead activated naïve B cells are expanded in active articular involvement in patients with systemic lupus erythematosus (SLE) 30
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 30
Long-term anti-TNF therapy and risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison among adalimumab, etanercept and infliximab 30
Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement 30
Malnutrition in COVID-19 survivors: prevalence and risk factors 29
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials 29
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 29
Long-term survival of anti-TNF therapy in a large italian cohort of rheumatoid arthritis patients: comparison among adalimumab, etanercept, and infliximab 29
ZAP70 B Cells and Plasmablasts As Markers of Disease Activity and Remission in Systemic LUPUS Erythematosus Nephritis 29
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 29
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study 29
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 29
Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries 29
Position paper of Italian rheumatologists on the use of biosimilar drugs 29
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 28
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 28
Gastrointestinal involvement in systemic vasculitis 28
Lupus eritematoso sistemico 28
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 28
Results of the classification criteria for cryoglobulinemic vasculitis validation study 28
Metaflammation, PEDF and Chemerin: Potential Systemic Factors Which Link Obesity To Response To Therapy In Early Rheumatoid Arthritis. 28
B-cell directed therapy in rheumatoid arthritis: predictive factors of efficacy and assessment of regeneration profile 28
The pathogenesis of microthrombi in COVID-19 cannot be controlled by DOAC: NETosis should be the target 28
Polymorphism of the immunoglobulin (IG) enhancer element HS1,2A gene and systemic lupus erythematosus 28
Metabolic syndrome, QTC interval lengthening and inflammation in rheumatoid arthritis. Analysis of their respective role 28
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 28
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 28
Validation of the classification criteria for cryoglobulinaemic vasculitis 27
Artrite reumatoide 27
Porphyromonas Gingivalis and the Pathogenesis of Rheumatoid Arthritis: Analysis of the Synovial Tissue and of Other Compartments 27
CD19+ cells subsets (CD5, CD38 and CD23) in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with disease activity and with auto-antibody levels 27
Metabolic syndrome in autoimmune diseases: prevalence and relationship with the inflammatory burden 27
Antineutrophil cytoplasmic autoantibodies (ANCA) positivity as a red flag of severe disease in lupus nephritis 27
Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA) 27
The body mass index: a determinant of remission in early rheumatoid arthritis 27
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial 27
Balance between hepatocyte growth factor (HGF) and transforming growth factor (TGF-BETA1) in renal biopsies of patients with lupus nephritis 26
EFFECTIVENESS AND SAFETY OF BELIMUMAB IN PATIENTSWITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC STUDY 26
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 26
Rheumatologic Symptoms in Patients with Mixed Cryoglobulinemia 26
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 26
Renal inflammatory infiltrate in lupus nephritis patients 26
CD19+ZAP70+ B cells value at baseline predicts response at T6 to BCDT (B cell depletion therapy). Recovery is mainly characterized by the appearance of naïve activated B cells and ZAP-70 positive B cells 26
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years 26
Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers 26
Totale 3.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 26 7 2 11 8 0 4
2021/202229 1 0 1 6 0 1 1 3 3 5 4 4
2022/2023277 28 13 28 43 21 25 0 27 45 30 16 1
2023/2024728 11 13 54 15 1 32 18 9 5 7 19 544
2024/20253.289 181 27 136 64 58 272 174 177 707 804 348 341
2025/20263.417 1.224 620 470 622 355 126 0 0 0 0 0 0
Totale 7.801